BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 120 filers reported holding BIOSCRIP INC in Q3 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $7,392,000 | -57.3% | 2,540,200 | -59.7% | 0.36% | -67.0% |
Q3 2017 | $17,326,000 | -37.3% | 6,300,200 | -38.1% | 1.10% | -18.4% |
Q2 2017 | $27,639,000 | +59.7% | 10,180,000 | 0.0% | 1.35% | +91.7% |
Q1 2017 | $17,306,000 | +63.5% | 10,180,000 | 0.0% | 0.70% | +27.4% |
Q4 2016 | $10,587,000 | -64.0% | 10,180,000 | 0.0% | 0.55% | -57.4% |
Q3 2016 | $29,420,000 | +13.3% | 10,180,000 | 0.0% | 1.29% | +3.0% |
Q2 2016 | $25,959,000 | +96.3% | 10,180,000 | +64.7% | 1.26% | +62.1% |
Q1 2016 | $13,225,000 | +26.0% | 6,180,000 | +3.0% | 0.77% | +14.0% |
Q4 2015 | $10,500,000 | -6.4% | 6,000,000 | 0.0% | 0.68% | -29.3% |
Q3 2015 | $11,220,000 | -33.5% | 6,000,000 | +29.0% | 0.96% | -16.4% |
Q2 2015 | $16,880,000 | +27.0% | 4,650,000 | +55.0% | 1.15% | +21.1% |
Q1 2015 | $13,290,000 | – | 3,000,000 | – | 0.95% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |